# Genesis Research Group launches Keystone IEGP Platform at ISPOR Europe 2026

- Published: 2026-11-06
- Author: [Healthcare News](https://healthcarenews.io/author/healthcarenews-io.md)
- Topics: [News](https://healthcarenews.io/news.md)
- Source: https://healthcarenews.io/news/genesis-research-group-launches-keystone-iegp-platform-at-ispor-europe-2026/
- Publication: Healthcare News
- Publisher: Connectively (Terkel, Inc.)
- Editorial policy: https://healthcarenews.io/editorial-policy/

![The Keystone IEGP logo](https://www.einpresswire.com/image/medium/1243619/keystone-logo.png)

Keystone IEGP Platform

[![Keystone screenshot](https://www.einpresswire.com/image/medium/1243621/keystone-screenshot.jpeg)](https://www.einpresswire.com/image/large/1243621/keystone-screenshot.png#1920x1043)

Keystone screenshot

[![An image of Genesis's new EVP, RWE/HEOR Sarah Alwardt](https://www.einpresswire.com/image/medium/1169095/sarah-alwardt-profile-shot.jpeg)](https://www.einpresswire.com/image/large/1169095/sarah-alwardt-profile-shot.jpeg#600x400)

Sarah Alwardt

*Genesis Research Group (Genesis) will launch Keystone, its modular platform for Integrated Evidence Generation Planning (IEGP), at ISPOR Europe 2026.*

**Organizations are under increasing pressure... Keystone helps teams align around a shared evidence agenda, prioritize the evidence that matters most, and connect evidence needs to actionable plans.”**

— Sarah Alwardt, PhD, Executive Vice President, RWE/HEOR

LONDON, UNITED KINGDOM, November 6, 2026 /[EINPresswire.com](https://www.einpresswire.com/)/ -- Built on Genesis's extensive experience developing value and evidence strategies and integrated evidence generation plans for global clients, Keystone enables life sciences organizations to connect value strategy, evidence, evidence gaps, prioritization, tactical planning and execution within a single, governed environment.  
  
Designed to support a living evidence strategy across the product lifecycle, the platform enables organizations to move beyond fragmented plans maintained across slide decks, spreadsheets and disconnected workstreams. Unlike traditional planning tools, it connects evidence, decisions and actions in a single digital workspace, helping teams maintain one product strategy, one evidence agenda and one set of shared priorities. The result is a coordinated, continuously managed process.  
  
"Organizations are under increasing pressure to make evidence planning decisions earlier, coordinate across more functions, and meet evolving global evidence requirements," said Sarah Alwardt, PhD, Executive Vice President, RWE/HEOR at Genesis Research Group. "Keystone was developed to help teams align around a shared evidence agenda, prioritize the evidence that matters most, and connect evidence needs to actionable plans."  
  
The launch coincides with Genesis's featured HEOR Theater presentation at ISPOR Europe, How Early Is Early Enough? Rethinking Evidence Planning for Today's Global Access Challenges, presented by Priti Jhingran, PhD, Vice President, Head of HEOR Strategy & Partnerships, on Monday, November 9, from 12:45-1:15 PM. The session will explore how organizations can move from evidence planning as a periodic exercise to a continuous, structured process that supports cross-functional alignment, transparent decision-making and evidence strategies that remain responsive to evolving market access requirements.  
  
Visitors to Booth 211 can see Keystone in action, try [EVID AI™](https://genesisrg.com/technology/evid-ai/), Genesis’s full-spectrum evidence synthesis platform, or learn about [RPR™](https://genesisrg.com/technology/rapid-payer-response/), its global payer and stakeholder engagement platform. They can also speak with Genesis experts about the latest developments in most-favored nation (MFN) pricing, HEOR, real-world evidence, and market access and pricing strategy.  
  
Genesis Research Group, an official ISPOR corporate partner, has contributed to 11 poster presentations in this year's scientific program, spanning artificial intelligence, health economics, market access, evidence synthesis and patient-centered outcomes research, with one poster recognized among the top 5% of research submissions to the event.  
  
Attendees are also invited to join Genesis for a complimentary reception at Booth 211 from 5:00-6:00 PM on Monday, November 9.  
  
To schedule a meeting or learn more about Keystone, visit Booth 211 at ISPOR Europe or visit [Genesisrg.com](https://genesisrg.com/technology/iep/).

Richard Chumbley  
Genesis Research Group  
[rchumbley@genesisrg.com](mailto:rchumbley@genesisrg.com)  
Visit us on social media:  
[LinkedIn](https://www.linkedin.com/company/genesisresearch)  
[YouTube](https://www.youtube.com/@genesisresearchgroup)

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

![](https://www.einpresswire.com/tracking/article.gif?aid=954984814&section=einpresswire&a=4c-JVj6PCNH37WGS&r=Ohkp76qG8AiWTQ6s&i=1ylDoKHweef6JfiW)

## Related

- [Robotimize and Damansara Specialist Hospital Bring Rehabilitation Technologies Closer to the Community](https://healthcarenews.io/news/robotimize-and-damansara-specialist-hospital-bring-rehabilitation-technologies-closer-to-t.md)
- [Overcoming Peptide DMPK Challenges: In Vitro, In Vivo, and Radiolabeled ADME CRO Solutions by WuXi AppTec DMPK](https://healthcarenews.io/news/overcoming-peptide-dmpk-challenges-in-vitro-in-vivo-and-radiolabeled-adme-cro-solutions-by.md)
- [The BioMEMS and Microsystem Market in Healthcare is Projected to Grow to $10.54 Billion by 2030 with a CAGR of 12.8%](https://healthcarenews.io/news/the-biomems-and-microsystem-market-in-healthcare-is-projected-to-grow-to-10-54-billion-by.md)
- [Biomedical Textiles Market Projected to Experience a Steady 9.4% CAGR Driven by Growing Industry Applications](https://healthcarenews.io/news/biomedical-textiles-market-projected-to-experience-a-steady-9-4-cagr-driven-by-growing-ind.md)